Position in GILD
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$2,097,957,640
+$230,421,420 QoQ
Shares Held
15,053,151
-1.1% QoQ
Ownership
1.21%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 91.86642052550991.ToString("F0")%
Shared 0.16650334537931627.ToString("F0")%
None 7.967076129110776.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$1,923,306
PutShares
13,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $22,910,045,373 across 16 Drug Manufacturers - General names. GILD ranks #5 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,821,962 | $5,334,160,377 | |
| 2 | LLY |
ELI LILLY & Co
|
4,860,408 | $4,470,457,455 | |
| 3 | ABBV |
AbbVie Inc.
|
13,278,161 | $2,887,867,228 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,713,363 | $2,251,030,425 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
15,053,151 | $2,097,957,640 | |
| 6 | PFE |
Pfizer Inc
|
53,879,900 | $1,512,947,580 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
23,301,337 | $1,413,226,077 | |
| 8 | AMGN |
Amgen Inc
|
3,793,443 | $1,334,722,908 |
All Filings in GILD
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,097,957,640 | 15,053,151 | Shares | Defined | 2026-05-05 | |
| 2026-03-31 | $1,923,306 | 13,800 | Put | Defined | 2026-05-05 | |
| 2025-12-31 | $3,866,310 | 31,500 | Put | Defined | 2026-02-10 | |
| 2025-12-31 | $1,867,536,220 | 15,215,384 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,581,567,183 | 14,248,353 | Shares | Defined | 2025-11-03 | |
| 2025-09-30 | $4,606,500 | 41,500 | Put | Defined | 2025-11-03 | |
| 2025-06-30 | $1,522,457,513 | 13,731,916 | Shares | Other | 2025-08-05 | |
| 2025-06-30 | $9,313,080 | 84,000 | Put | Defined | 2025-08-05 | |
| 2025-03-31 | $9,412,200 | 84,000 | Put | Defined | 2025-04-29 | |
| 2025-03-31 | $1,770,791,800 | 15,803,586 | Shares | Other | 2025-04-29 | |
| 2024-12-31 | $1,547,810,917 | 16,756,641 | Shares | Defined | 2025-02-04 | |
| 2024-12-31 | $8,590,410 | 93,000 | Put | Defined | 2025-02-04 | |
| 2024-09-30 | $1,167,953,649 | 13,930,745 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $970,018,599 | 14,138,152 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,074,832,914 | 14,673,487 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $1,255,566,364 | 15,498,906 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $1,152,916,444 | 15,384,527 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $1,345,096,688 | 17,452,922 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $1,411,502,556 | 17,012,204 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $1,420,440,524 | 16,545,609 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $951,348,378 | 15,421,436 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $830,378,897 | 13,434,378 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $755,040,794 | 12,700,434 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $941,043,530 | 12,960,247 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $884,356,176 | 12,660,790 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $873,816,179 | 12,689,750 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $843,782,579 | 13,055,587 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $1,038,308,880 | 16,431,538 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $1,296,722,208 | 16,853,681 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,414,889,734 | 18,925,759 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||